SEC Form 4 · accession 0001179110-18-013894
AbbVie Inc. · ABBV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laura J Schumacher
Officer — Executive Vice President
Period of report
Dec 13, 2018
Accepted (ET)
Dec 14, 2018 · 5:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551152
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.01 par valueF1 | Dec 13, 2018 | A | 112,530 | $0.00 | A | 210,788 | D | |
| Common stock, $0.01 par value | Dec 13, 2018 | F | 49,852 | $88.60 | D | 160,936 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2, above, upon certification by the Compensation Committee of AbbVie's Board of Directors of the achievement of specified strategic milestones.